Your browser doesn't support javascript.
loading
Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Reduces Infarct Size Independently of Sodium Glucose Cotransporter-2.
Chen, Sha; Wang, Qian; Christodoulou, Andriana; Mylonas, Nikolaos; Bakker, Diane; Nederlof, Rianne; Hollmann, Markus W; Weber, Nina C; Coronel, Ruben; Wakker, Vincent; Christoffels, Vincent M; Andreadou, Ioanna; Zuurbier, Coert J.
Afiliação
  • Chen S; Laboratory of Experimental Intensive Care and Anesthesiology, Department of Anesthesiology (S.C., Q.W., D.B., M.W.H.., N.C.W., C.J.Z.), Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, the Netherlands.
  • Wang Q; Laboratory of Experimental Intensive Care and Anesthesiology, Department of Anesthesiology (S.C., Q.W., D.B., M.W.H.., N.C.W., C.J.Z.), Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, the Netherlands.
  • Christodoulou A; Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Greece (A.C., N.M., I.A.).
  • Mylonas N; Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Greece (A.C., N.M., I.A.).
  • Bakker D; Laboratory of Experimental Intensive Care and Anesthesiology, Department of Anesthesiology (S.C., Q.W., D.B., M.W.H.., N.C.W., C.J.Z.), Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, the Netherlands.
  • Nederlof R; Institut für Herz- und Kreislaufphysiologie, Medizinische Fakultät und Universitätsklinikum Düsseldorf, Heinrich-Heine-Universität Düsseldorf, Germany (R.N.).
  • Hollmann MW; Laboratory of Experimental Intensive Care and Anesthesiology, Department of Anesthesiology (S.C., Q.W., D.B., M.W.H.., N.C.W., C.J.Z.), Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, the Netherlands.
  • Weber NC; Laboratory of Experimental Intensive Care and Anesthesiology, Department of Anesthesiology (S.C., Q.W., D.B., M.W.H.., N.C.W., C.J.Z.), Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, the Netherlands.
  • Coronel R; Department of Experimental Cardiology (R.C.), Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, the Netherlands.
  • Wakker V; Department of Medical Biology (V.W., V.M.C.), Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, the Netherlands.
  • Christoffels VM; Department of Medical Biology (V.W., V.M.C.), Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, the Netherlands.
  • Andreadou I; Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Greece (A.C., N.M., I.A.).
  • Zuurbier CJ; Laboratory of Experimental Intensive Care and Anesthesiology, Department of Anesthesiology (S.C., Q.W., D.B., M.W.H.., N.C.W., C.J.Z.), Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, the Netherlands.
Circulation ; 147(3): 276-279, 2023 01 17.
Article em En | MEDLINE | ID: mdl-36649392
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Idioma: En Ano de publicação: 2023 Tipo de documento: Article